APPLIKATOR

European patent · EP2730310 · In force

Register entry

Publication number
EP2730310
Application number
EP12807991
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 4, 2012
Published
May 14, 2014
Granted
Jun 15, 2022
Protection ends at the latest
Jul 3, 2032
Next annual fee due
Jul 31, 2027
IPC classes
A61M 35/00 (2006.01)
A45D 34/04 (2006.01)
A61J 1/05 (2006.01)
Priority
JP 2011149605 05.07.2011
PCT application
PCT/JP2012/004352 04.07.2012
PCT publication
WO2013/005434 10.01.2013
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Apr 26, 2023

    Change

    Published in Swissreg on 26.04.2023

  6. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  7. Jun 15, 2022

    Granted

    Published in Swissreg on 15.06.2022

Parties

Holder

Kaken Pharmaceutical Co., Ltd.

28-8, Honkomagome 2-chome Bunkyo-ku, Tokyo 113-8650, JP

Inventor

UETA, Masahiro

Tokyo 113-8650, JP

TAKEI, Ryouji

Souka-shi Saitama 340-0017, JP

TAGUCHI, Katsuya

Tokyo 101-0026, JP

SAKAGUCHI, Ryouhei

Ichinomiya-shi, Aichi 4910072, JP

SASAMA, Katsumi

Tokyo 130-0026, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.